Finance

In this article

A worker stacks cases of Constellation Brands’ Corona beer for delivery at the Euclid Beverage LLC warehouse in Peru, Illinois.
Daniel Acker | Bloomberg | Getty Images

Shares of Constellation Brands fell Thursday after the wine, beer and spirits company reported ongoing supply chain costs that offset sales growth in its beer category.

The stock closed down nearly 9% Thursday.

The company, which makes Corona beer and Svedka vodka, also lowered its earnings out look for the fiscal year. Constellation said it now projects earnings of $11 to $11.20 per share for the year, down from its previous guidance of $11.20 to $11.60 per share. 

For the three months ended Nov. 30, Constellation’s beer segment posted year-over-year net sales growth of 8%, driven by continued growth of its Modelo Especial and Modelo Chelada brands.

However, the company cited higher costs from raw materials, packaging and logistics, brewery expansions and marketing, which offset beer sales growth.

In a conference call with analysts Tuesday morning, Chief Executive Officer Bill Newlands added that a “recent series of headwinds” hit the company’s beer business towards the end of its fiscal third quarter, including poor weather and economic conditions in California.

Its operating margin in the beer business decreased during the quarter to 37.5% from 41.3% a year earlier.

The company said it plans to continue price increases on its beer products to match higher operating costs plaguing its supply chain.

For its third quarter, Constellation’s over net income fell to $467.7 million, or $2.52 a share, from $470.8 million, or $2.48 a share, from a year ago.

Articles You May Like

Weekly Market Outlook (18-22 November)
ForexLive European FX news wrap: Dollar ramps higher as post-election run continues
Disney narrowly beats estimates as streaming boosts entertainment segment
Yen Slips Slightly as BoJ Offers No Clues on Rate Hike, Kiwi Struggles After Weak Services Data
NZD/USD Price Analysis: Pair saw a volatile session, high near 20-day SMA then retreated